Biologic Outsourcing STREAM
-
Meet The Experts: Part 1 - Process Analytical Technology (PAT)
5/1/2023
Watch part 1 of this 4-part interview series to learn about process analytical technology (PAT) from expert Stacy Shollenberger.
-
Master Your mRNA Manufacturing
3/4/2025
Join pDNA and mRNA specialists as they discuss innovative mRNA manufacturing solutions for your purification challenges, mRNA stability, and overall product quality.
-
Flexible Manufacturing That Fits Your Molecule
5/28/2026
Complex molecule manufacturing doesn’t follow an established playbook. See how we combine a thorough understanding of client processes and requirements to generate high-quality biologics
-
Your Roadmap For Efficient Processes
3/4/2025
Struggling with mRNA integrity? Discover essential strategies to boost stability in mRNA manufacturing with innovative endonuclease-free DTT and Spermidine chemicals.
-
Explore What's Next: Product Characterization
7/17/2019
Newer, high-resolution analytical techniques help answer questions regarding product heterogeneity and drug functions, and help assess for product-related aggregates and impurities.
-
A Targeted Molecular Method For Sensitive Viral Detection In Just Days
6/13/2025
Explore the motivations, scientific breakthroughs, and collaborative efforts that contributed to the development of this innovative testing solution to help drive safer, animal-free biomanufacturing solutions.
-
Delivering Top Quality Fill Finish Manufacturing
Bringing an innovative parenteral drug product to market requires a fill finish manufacturing partner with the resources and solutions to deliver top quality products and the agility to meet your needs.
-
CHO Fed-batch Portfolio: Cellvento® And EX-CELL® Advanced Media And Feeds
3/11/2021
Cellvento® and EX-CELL® Advanced cell culture media supports consistent growth and performance from development to production. Get the enhanced performance, assured regulatory compliance and the security of supply necessary in today’s biopharmaceutical environment.
-
10 Minutes On Optimizing Upstream Process Development
3/25/2025
Gain insight into how UPD ensures scalable and compliant processes, facilitates the efficient development of innovative therapeutics, and contributes to molecule development and production.
-
Biotherapy Characterization: Binding Assays
7/17/2019
MilliporeSigma Senior Scientist Helen Hsu, Ph.D. describes how, with our custom binding assays, and supported with our comprehensive off-the-shelf Fc gamma receptor binding assays, we can help you optimize your mAb production, from clone development through upstream and downstream processes.